# To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers

> **NCT01045863** · PHASE1 · TERMINATED · sponsor: **Pfizer** · enrollment: 10 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-03382792 Cohort 1
- **DRUG:** PF-03382792 Cohort 2
- **DRUG:** PF-03382792
- **DRUG:** Food Effect cohort
- **DRUG:** CSF cohort

## Key facts

- **NCT ID:** NCT01045863
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** See termination reason in detailed description.
- **Last updated:** 2010-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01045863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01045863, "To Evaluate Safety, Tolerability, Plasma Drug Levels And Other Biological Effects In Healthy Volunteers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01045863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*